The global pompe disease treatment market size was valued at USD 1.2 billion in 2022 and is poised to grow at a significant CAGR of 8% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....
The Pompe Disease Treatment Market Insights and Analysis by Type .Therapy (Enzyme Replacement Therapy, Gene Therapy, Others), End-User (Hospitals and Clinics; Research and Academic Institutes) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2032
The lack of mutation of the GAA gene causes glycogen buildup, which triggers heart problems,...
The pompe disease treatment market is anticipated to reach USD 1.538 Billion by 2032 at 3.80% CAGR during the forecast period 2023-2032.
The lack of mutation of the GAA gene causes glycogen buildup, which triggers heart problems, muscular weakness, and liver damage, all of which can lead to early mortality in newborns is increasingly being detected.
Due to various massive...
The Pompe Disease Treatment Market Outlook and Analysis by Type, Therapy, End-User and Region - Forecast till 2030
The pompe disease treatment market is anticipated to reach USD 1,409.09 Million by 2030 at 3.80% CAGR during the forecast period 2022-2030.
The lack of mutation of the GAA gene causes glycogen buildup, which triggers heart problems, muscular weakness, and liver damage, all of which...